Germline Testing in Breast Cancer: A Single-Center Analysis Comparing Strengths and Challenges of Different Approaches
Although MGPT increases hereditary BC detection, its complexity requires clear guidelines for optimal clinical management and strategies for merging the benefits of SGT and MGPT.
Authors
- Monica Marabelli (ORCID: https://orcid.org/0000-0003-4216-230X)
- Mariarosaria Calvello (ORCID: https://orcid.org/0000-0003-2113-8503)
- Sara Gandini (ORCID: https://orcid.org/0000-0002-1348-4548)
- Francesca Fava (ORCID: https://orcid.org/0000-0002-4363-2353)
- Matteo Lazzeroni (ORCID: https://orcid.org/0000-0002-2162-4002)
- Matteo Dal Molin
- Irène Feroce (ORCID: https://orcid.org/0000-0001-9312-2020)
- Aliana Guerrieri‐Gonzaga (ORCID: https://orcid.org/0000-0003-1915-1688)
- Sara Mannucci
- Francesco Bertolini (ORCID: https://orcid.org/0000-0001-5660-3255)
- Cristina Zanzottera (ORCID: https://orcid.org/0000-0001-5691-722X)
- Bernardo Bonanni (ORCID: https://orcid.org/0000-0003-3589-2128)
- Elena Marino
- Chiara Morocutti
Institutions
- European Institute of Oncology (IT)
Publication Details
- Journal
- Cancers
- Published
- 2025-04-24
- DOI
- https://doi.org/10.3390/cancers17091419
- Citations
- 1
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- Ministero della Salute